ATOS Insider Trading

Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $51,250.00
Insider Selling (Last 12 Months): $0.00

Atossa Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Atossa Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40k-$20k$0$20k$40kTotal Insider BuyingTotal Insider Selling

Atossa Therapeutics Share Price & Price History

Current Price: $0.65
Price Change: Price Decrease of -0.0219 (-3.25%)
As of 04/1/2025 05:00 PM ET

This chart shows the closing price history over time for ATOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.67Closing price on 03/31/25:

Atossa Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Atossa Therapeutics (NASDAQ:ATOS)

12.74% of Atossa Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATOS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$649kbought$49ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal InflowsTotal Outflows
Atossa Therapeutics logo
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Read More on Atossa Therapeutics

Today's Range

Now: $0.65
Low: $0.65
High: $0.70

50 Day Range

MA: $0.79
Low: $0.67
High: $0.96

52 Week Range

Now: $0.65
Low: $0.65
High: $2.31

Volume

504,103 shs

Average Volume

981,925 shs

Market Capitalization

$84.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Atossa Therapeutics?

Atossa Therapeutics' top insider investors include:
  1. Jonathan Finn (Director)
  2. H Lawrence Remmel (Director)
Learn More about top insider investors at Atossa Therapeutics.